References
- Adams G.E., Ahmed I., Sheldon P.W., Stratford I.J. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. British Journal of Cancer 1984a; 49: 571–578
- Adams G.E., Ahmed I., Sheldon P.W., Stratford I.J. RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivo. International Journal of Radiation Oncology, Biology and Physics 1984b; 10: 1653–1656
- Adams G.E., Clarke E.D., Flockhart I.R., Jacobs R.S., Sehmi D.S., Stratford I.J., Wardman P., Watts M.E., Parrick J., Wallace R.C., Smithen C.E. Structure-activity relationships in the development of hypoxic cell radiosensitizers, I. Sensitizing efficiency. International Journal of Radiation Biology 1979; 35: 133–150
- Adams G.E., Flockhart I.R., Smithen C.E., Stratford I.J., Wardman P., Watts M.E. Electron-affinic sensitization, VII. A correlation between structure, one-electron reduction potentials and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiation Research 1976; 67: 9–20
- Ahmed I., Jenkins T.C., Walling J.M., Stratford I.J., Sheldon P.W., Adams G.E., Fielden E.M. Radiosensitization and toxicity in vitro and in vivo by analogues of RSU 1069. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1079–1081
- Dennis M.F., Stratford M.R.L., Wardman P., Watts M.E. Cellular uptake of misonidazole and analogues with acidic or basic functions. International Journal of Radiation Biology 1985; 47: 629–643
- Dische S., Saunders M.I., Bennett M.H., Dunphy E.P., Des Rochers C., Stratford M.R.L., Minchington A.I., Wardman P. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799. British Journal of Radiology 1986; 59: 911–917
- Horwich A., Holliday S.B., Deacon J.M., Peckman M.J. A toxicity and pharmacokinetic study in man of the hypoxic cell radiosensitizer RSU 1069. British Journal of Radiology 1986; 59: 1238–1240
- O'Neill P., Jenkins T.C., Stratford I.J., Silver A.R.J., Ahmed I., McNeil S.S., Fielden E.M., Adams G.E. Mechanism of action of some bioreducible 2-nitroimidazoles: Comparison of in vitro cytotoxicity and ability to induce DNA strand breakage. Anti-Cancer Drug Design 1987; 1: 271–280
- Roberts J.T., Bleehen N.M., Workman P., Walton M.I. A phase I study of the hypoxic cell radiosensitizer Ro 03-8799. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1755–1758
- Saunders M.I., Anderson P.J., Bennett M.H., Dische S., Minchington A., Stratford M.R.L., Tothill M. The clinical testing of Ro 03-8799: Pharmacokinetics, toxicology, tissue and tumour concentrations. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1759–1763
- Saunders M.I., Dische S., Fermont D., Bishop A., Lennox-Smith I., Allen J.G., Malcolm S.L. The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study. British Journal of Cancer 1982; 46: 706–710
- Silver A.R.J., O'Neill P., Jenkins T.C. Induction of DNA strand breaks by RSU 1069, a nitroimidazole-aziridine radiosensitizer. Biochemical Pharmacology 1985; 34: 3537–3542
- Smithen C.E., Clarke E.D., Dale J.A., Jacobs R.S., Wardman P., Watts M.E., Woodcock M. Novel (nitro-1-imidazolyl)-alkanolamines as potential radiosensitizers with improved therapeutic properties. Radiation Sensitizers: their use in the clinical management of cancer, L.W. Brady. Masson, New York 1980; 22–32
- Stratford I.J., Walling J.M., Silver A.R.J. The differential cytotoxicity of RSU 1069: Cell survival studies indicating interaction with DNA as a possible mode of action. British Journal of Cancer 1986; 53: 339–344
- Walling J.M., Stratford I.J., Adams G.E., Silver A.R.J., Ahmed I., Jenkins T.C., Fielden E.M. Studies on the radiosensitizing and cytotoxic properties of RSU 1069 and its analogues. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1083–1086
- Wardman P. Molecular structure and biological activity of hypoxic cell radiosensitizers and hypoxia specific cytotoxins. Advanced Topics on Radiosensitizers of Hypoxic Cells, A. Breccia, C. Rimondi, G.E. Adams. NATO Advanced Study Institutes Series A43, Plenum, New York 1982; 49–76
- Watts M.E., Jones N.R. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues. International Journal of Radiation Biology 1985; 47: 645–653